StockData
Beam Therapeutics Inc. logo

Beam Therapeutics Inc. (BEAM) stock

BEAMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3014% below fair value
$20.65−0.29 (-1.38%)

Close on Nov 17, 2026Market cap $2.13BP/E –Yield –

Beam Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Beam Therapeutics's total debt was $100.26M at Jun 30, 2026.

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$100.26M–
Q1 FY2026Mar 31, 2026$100.19M–

More Beam Therapeutics figures

See a number that looks wrong?